ITCI Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.70%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $26,521,760.03

Intra-Cellular Therapies Insider Trading History Chart

Intra-Cellular Therapies Share Price & Price History

^$47.82

▼ -0.1 (-0.21%)

As of 02/1/2023 01:00 AM ET

Days: 30 | 90 | 365

Profit From the Commercial Solar Boom?

From Investing Trends | Ad

Solar energy had its best year ever in 2021, with a record 24 gigawatts of power installed. That's enough to power 18 million homes! Analysts expect the global solar farm market to reach $356 billion by 2028. The utility segment of the solar market is expected to grow at the highest annual growth rate in the industry, especially with the many tax incentives now offered.

See What's Going on With the Solar Industry

Intra-Cellular Therapies Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/19/2022	Joel S. Marcus	Director	Sell	5,000	$50.82	$254,100.00	29,233
12/13/2022	Sharon Mates	CEO	Sell	33,083	$55.00	$1,819,565.00	1,100,309
12/1/2022	Michael Halstead	EVP	Sell	50,000	$53.73	$2,686,500.00
9/21/2022	Lawrence J. Hineline	CFO	Sell	65,164	$45.63	$2,973,433.32
8/11/2022	Nostrand Robert L Van	Director	Sell	30,000	$57.13	$1,713,900.00	9,043
5/12/2022	Joel S. Marcus	Director	Sell	10,000	$55.00	$550,000.00	54,233
4/8/2022	Mark Neumann	EVP	Sell	86,348	$64.37	$5,558,220.76	45,339
3/18/2022	Rory B. Riggs	Director	Sell	20,637	$61.18	$1,262,571.66
3/16/2022	Rory B. Riggs	Director	Sell	64,534	$59.27	$3,824,930.18
3/7/2022	Joel S. Marcus	Director	Sell	5,000	$54.52	$272,600.00
3/4/2022	Suresh K. Durgam	Insider	Sell	3,860	$55.52	$214,307.20
3/2/2022	Suresh K. Durgam	Insider	Sell	4,177	$56.98	$238,005.46
2/24/2022	Lawrence J. Hineline	CFO	Sell	7,454	$51.97	$387,384.38
2/24/2022	Mark Neumann	EVP	Sell	7,906	$52.21	$412,772.26
2/24/2022	Sharon Mates	CEO	Sell	22,589	$51.98	$1,174,176.22
2/24/2022	Suresh K. Durgam	Insider	Sell	4,046	$52.27	$211,484.42
2/22/2022	Lawrence J. Hineline	CFO	Sell	10,443	$55.40	$578,542.20
2/22/2022	Mark Neumann	EVP	Sell	11,139	$55.29	$615,875.31
2/22/2022	Sharon Mates	CEO	Sell	27,847	$55.39	$1,542,445.33
2/22/2022	Suresh K. Durgam	Insider	Sell	4,177	$55.29	$230,946.33
1/18/2022	Suresh K. Durgam	Insider	Sell	6,223	$42.03	$261,552.69
1/10/2022	Lawrence J. Hineline	CFO	Sell	19,639	$40.76	$800,485.64
1/10/2022	Mark Neumann	EVP	Sell	20,948	$40.78	$854,259.44
1/10/2022	Sharon Mates	CEO	Sell	41,896	$40.78	$1,708,518.88
1/10/2022	Suresh K. Durgam	Insider	Sell	6,870	$40.76	$280,021.20
12/21/2021	Lawrence J. Hineline	CFO	Sell	175,000	$47.59	$8,328,250.00
12/21/2021	Michael Halstead	EVP	Sell	176,863	$47.56	$8,411,604.28
10/18/2021	Mark Neumann	EVP	Sell	13,448	$40.86	$549,485.28
10/18/2021	Sharon Mates	CEO	Sell	8,192	$40.00	$327,680.00
10/15/2021	Sharon Mates	CEO	Sell	40,392	$40.00	$1,615,680.00
6/14/2021	Joel S. Marcus	Director	Sell	18,289	$42.27	$773,076.03	13,767
5/27/2021	Christopher D. Alafi	Director	Sell	8,482	$40.01	$339,364.82	346,795
5/24/2021	Christopher D. Alafi	Director	Sell	26,575	$40.47	$1,075,490.25	346,795
5/21/2021	Christopher D. Alafi	Director	Sell	1,100	$40.00	$44,000.00	346,795
2/19/2021	Lawrence J. Hineline	CFO	Sell	10,442	$39.23	$409,639.66	10,442
2/19/2021	Mark Neumann	EVP	Sell	5,184	$39.22	$203,316.48	50,523
2/19/2021	Sharon Mates	CEO	Sell	27,847	$39.23	$1,092,437.81	1,161,239
2/19/2021	Suresh K. Durgam	Insider	Sell	2,734	$39.25	$107,309.50	25,838
1/11/2021	Lawrence J. Hineline	CFO	Sell	19,638	$32.02	$628,808.76
1/11/2021	Mark Neumann	EVP	Sell	9,684	$32.02	$310,081.68	49,068
1/11/2021	Sharon Mates	CEO	Sell	41,896	$32.01	$1,341,090.96	1,175,288
1/11/2021	Suresh K. Durgam	Insider	Sell	4,367	$32.12	$140,268.04	21,851
1/4/2021	Lawrence J. Hineline	CFO	Sell	15,810	$31.31	$495,011.10
1/4/2021	Michael Halstead	EVP	Sell	16,160	$31.30	$505,808.00
1/4/2021	Sharon Mates	CEO	Sell	48,341	$31.30	$1,513,073.30
11/17/2020	Michael Halstead	EVP	Sell	79,425	$27.62	$2,193,718.50	79,425
11/11/2020	Lawrence J. Hineline	CFO	Sell	28,034	$25.41	$712,343.94	18,034
11/4/2020	Sharon Mates	CEO	Sell	50,000	$25.00	$1,250,000.00	1,163,392
10/16/2020	Mark Neumann	EVP	Sell	6,792	$26.80	$182,025.60	34,912
9/14/2020	Christopher D. Alafi	Director	Buy	49,500	$29.60	$1,465,200.00	345,223
9/11/2020	Christopher D. Alafi	Director	Buy	21,000	$28.08	$589,680.00
9/9/2020	Lawrence J. Hineline	CFO	Sell	41,983	$31.14	$1,307,350.62	50,017
5/13/2020	Joel S. Marcus	Director	Sell	7,297	$20.63	$150,537.11	14,374
5/11/2020	Joel S. Marcus	Director	Sell	50,000	$19.95	$997,500.00	14,374

Profit From the Commercial Solar Boom?

From Investing Trends | Ad

See What's Going on With the Solar Industry

SEC Filings (Institutional Ownership Changes) for Intra-Cellular Therapies (NASDAQ:ITCI)

86.95% of Intra-Cellular Therapies stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Intra-Cellular Therapies Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/1/2023	Bank of Montreal Can	461,300	$24.72M	0.0%	-0.1%	0.487%
2/1/2023	State of New Jersey Common Pension Fund D	55,431	$2.93M	0.0%	+4.6%	0.059%
2/1/2023	Legato Capital Management LLC	14,487	$0.77M	0.1%	N/A	0.015%
2/1/2023	Vahanian & Associates Financial Planning Inc.	18,592	$0.98M	3.2%	-30.6%	0.020%
2/1/2023	Pinnacle Associates Ltd.	195,057	$10.32M	0.2%	-1.7%	0.206%
2/1/2023	DekaBank Deutsche Girozentrale	35,000	$1.85M	0.0%	-19.0%	0.037%
1/31/2023	AE Wealth Management LLC	11,137	$0.59M	0.0%	N/A	0.012%
1/31/2023	Knights of Columbus Asset Advisors LLC	23,506	$1.24M	0.1%	+104.6%	0.025%
1/30/2023	New York State Common Retirement Fund	136,815	$7.24M	0.0%	+9.2%	0.144%
1/27/2023	Exchange Traded Concepts LLC	2,687	$0.14M	0.0%	+14.4%	0.003%
1/27/2023	Natixis Advisors L.P.	27,448	$1.45M	0.0%	+30.7%	0.029%
1/27/2023	Alpha DNA Investment Management LLC	21,432	$1.13M	0.4%	N/A	0.023%
1/26/2023	Strs Ohio	21,600	$1.14M	0.0%	-30.1%	0.023%
1/25/2023	Pinnacle Associates Ltd.	194,437	$10.16M	0.2%	-2.0%	0.205%
1/24/2023	Park Avenue Securities LLC	4,838	$0.26M	0.0%	-5.1%	0.005%
1/23/2023	Allspring Global Investments Holdings LLC	8,906	$0.47M	0.0%	-83.6%	0.009%
1/20/2023	Quantum Private Wealth LLC	15,659	$0.83M	0.5%	-5.7%	0.017%
1/19/2023	Crossmark Global Holdings Inc.	7,662	$0.41M	0.0%	+9.8%	0.008%
1/18/2023	Exchange Traded Concepts LLC	2,687	$0.14M	0.0%	+14.4%	0.003%
1/12/2023	First Hawaiian Bank	6,558	$0.35M	0.0%	-8.9%	0.007%
1/12/2023	Hennion & Walsh Asset Management Inc.	11,148	$0.59M	0.0%	N/A	0.012%
1/12/2023	Assenagon Asset Management S.A.	80,228	$4.25M	0.0%	+69.2%	0.085%
12/8/2022	Bank of New York Mellon Corp	388,559	$18.08M	0.0%	+1.3%	0.410%
11/22/2022	Teachers Retirement System of The State of Kentucky	23,594	$1.10M	0.0%	N/A	0.025%
11/21/2022	California State Teachers Retirement System	109,226	$5.08M	0.0%	-0.8%	0.115%
11/17/2022	M&T Bank Corp	5,888	$0.27M	0.0%	+59.5%	0.006%
11/16/2022	Balyasny Asset Management LLC	5,308	$0.25M	0.0%	N/A	0.006%
11/16/2022	Fred Alger Management LLC	38,536	$1.79M	0.0%	-54.5%	0.041%
11/16/2022	SeaCrest Wealth Management LLC	9,090	$0.42M	0.1%	-12.1%	0.010%
11/16/2022	BNP Paribas Arbitrage SNC	53,714	$2.50M	0.0%	+26.0%	0.057%
11/15/2022	Nomura Holdings Inc.	167,697	$7.80M	0.0%	N/A	0.177%
11/15/2022	Alliancebernstein L.P.	2,200,408	$102.39M	0.0%	+4.2%	2.323%
11/15/2022	State Street Corp	1,976,223	$91.95M	0.0%	+2.9%	2.087%
11/15/2022	Castleark Management LLC	88,180	$4.10M	0.2%	-2.2%	0.093%
11/15/2022	Pier Capital LLC	144,038	$6.70M	1.2%	+23.5%	0.152%
11/15/2022	Public Employees Retirement System of Ohio	68,509	$3.19M	0.0%	-15.9%	0.072%
11/15/2022	Tang Capital Management LLC	640,000	$29.78M	3.7%	-8.6%	0.676%
11/15/2022	Twinbeech Capital LP	107,391	$5M	0.1%	N/A	0.113%
11/15/2022	UBS Asset Management Americas Inc.	185,832	$8.65M	0.0%	-23.1%	0.196%
11/15/2022	Vanguard Group Inc.	8,116,020	$377.64M	0.0%	+0.4%	8.570%
11/15/2022	Prelude Capital Management LLC	9,217	$0.43M	0.0%	-17.1%	0.010%
11/15/2022	Price T Rowe Associates Inc. MD	350,956	$16.33M	0.0%	+761.4%	0.371%
11/15/2022	Polar Asset Management Partners Inc.	71,600	$3.33M	0.0%	N/A	0.076%
11/15/2022	Lord Abbett & CO. LLC	2,018,686	$93.93M	0.3%	+9.1%	2.131%
11/15/2022	Engineers Gate Manager LP	20,923	$0.97M	0.1%	-48.5%	0.022%
11/15/2022	Ensign Peak Advisors Inc	24,340	$1.13M	0.0%	-80.6%	0.026%
11/15/2022	First Trust Advisors LP	96,455	$4.49M	0.0%	-10.6%	0.102%
11/15/2022	Financial Advocates Investment Management	2,788	$0.47M	0.0%	N/A	0.003%
11/15/2022	Bank of New York Mellon Corp	388,559	$18.08M	0.0%	+1.3%	0.410%
11/15/2022	Bellevue Group AG	3,329,279	$154.91M	2.2%	-0.6%	3.515%
11/15/2022	BlackRock Inc.	7,102,050	$330.46M	0.0%	+0.8%	7.499%
11/14/2022	AlphaCrest Capital Management LLC	4,982	$0.23M	0.0%	-51.3%	0.005%
11/14/2022	Macquarie Group Ltd.	451,920	$21.08M	0.0%	-14.1%	0.477%
11/14/2022	Zacks Investment Management	8,486	$0.40M	0.0%	+18.1%	0.009%
11/14/2022	Royal Bank of Canada	43,911	$2.04M	0.0%	+131.8%	0.046%
11/14/2022	Tudor Investment Corp Et Al	50,158	$2.33M	0.1%	+167.8%	0.053%
11/14/2022	Point72 Asset Management L.P.	655,800	$30.51M	0.1%	N/A	0.692%
11/14/2022	Cubist Systematic Strategies LLC	48,976	$2.28M	0.0%	-6.3%	0.052%
11/14/2022	Guggenheim Capital LLC	9,357	$0.44M	0.0%	+7.3%	0.010%
11/14/2022	PDT Partners LLC	13,493	$0.63M	0.1%	N/A	0.014%
11/14/2022	Verition Fund Management LLC	69,356	$3.23M	0.0%	-33.3%	0.073%
11/14/2022	Ergoteles LLC	15,742	$0.73M	0.0%	+341.3%	0.017%
11/14/2022	Samlyn Capital LLC	537,888	$25.03M	0.5%	+16.2%	0.568%
11/14/2022	Moore Capital Management LP	180,185	$8.38M	0.2%	-3.3%	0.190%
11/14/2022	Nuveen Asset Management LLC	558,724	$26M	0.0%	-12.5%	0.590%
11/14/2022	Canada Pension Plan Investment Board	8,800	$0.41M	0.0%	N/A	0.009%
11/14/2022	Altium Capital Management LP	100,000	$4.65M	1.7%	+33.3%	0.106%
11/14/2022	MetLife Investment Management LLC	48,717	$2.27M	0.0%	+2.4%	0.051%
11/14/2022	Pictet Asset Management SA	844,924	$39.32M	0.1%	-24.1%	0.892%
11/14/2022	Cipher Capital LP	5,308	$0.25M	0.0%	N/A	0.006%
11/14/2022	Ghost Tree Capital LLC	60,000	$2.79M	0.8%	N/A	0.063%
11/14/2022	Oppenheimer Asset Management Inc.	30,466	$1.42M	0.0%	+63.9%	0.032%
11/14/2022	CenterBook Partners LP	6,701	$0.31M	0.1%	N/A	0.007%
11/10/2022	Envestnet Asset Management Inc.	58,935	$2.74M	0.0%	+1,524.9%	0.062%
11/10/2022	Credit Suisse AG	77,394	$3.60M	0.0%	+4.9%	0.082%
11/10/2022	Miramar Capital LLC	21,995	$1.10M	0.3%	-23.6%	0.023%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	11,025	$0.51M	0.0%	+7.5%	0.012%
11/10/2022	Hillsdale Investment Management Inc.	94,000	$4.37M	0.4%	+566.7%	0.099%
11/10/2022	Knights of Columbus Asset Advisors LLC	11,490	$0.54M	0.1%	+13.5%	0.012%
11/10/2022	Dimensional Fund Advisors LP	730,882	$34.01M	0.0%	-3.0%	0.772%
11/10/2022	Tower Research Capital LLC TRC	6,263	$0.29M	0.0%	+57.9%	0.007%
11/10/2022	Bank of Montreal Can	461,731	$21.61M	0.0%	+0.2%	0.488%
11/10/2022	UBS Group AG	2,606	$0.12M	0.0%	-26.6%	0.003%
11/9/2022	California Public Employees Retirement System	204,223	$9.50M	0.0%	+117.4%	0.216%
11/8/2022	Mutual of America Capital Management LLC	37,362	$1.74M	0.0%	N/A	0.039%
11/8/2022	International Biotechnology Trust PLC	221,856	$10.30M	3.3%	+6,057.5%	0.234%
11/8/2022	Atom Investors LP	21,021	$0.98M	0.3%	-33.1%	0.022%
11/8/2022	New York State Common Retirement Fund	125,234	$5.83M	0.0%	-31.3%	0.132%
11/8/2022	OLD National Bancorp IN	50,776	$2.36M	0.1%	-2.3%	0.054%
11/8/2022	Eagle Asset Management Inc.	254,957	$11.86M	0.1%	-2.5%	0.269%
11/7/2022	Inspire Investing LLC	4,447	$0.21M	0.0%	N/A	0.005%
11/7/2022	Nisa Investment Advisors LLC	4,462	$0.21M	0.0%	+9.1%	0.005%
11/7/2022	Fox Run Management L.L.C.	8,357	$0.39M	0.2%	-4.1%	0.009%
11/7/2022	Quantbot Technologies LP	1,189	$55K	0.0%	N/A	0.001%
11/7/2022	Level Four Advisory Services LLC	7,450	$0.35M	0.0%	-48.4%	0.008%
11/7/2022	Arizona State Retirement System	23,069	$1.07M	0.0%	+2.4%	0.024%
11/7/2022	Jump Financial LLC	10,000	$0.47M	0.0%	N/A	0.011%
11/7/2022	ProShare Advisors LLC	18,025	$0.84M	0.0%	+2.2%	0.019%
11/4/2022	Commerce Bank	7,665	$0.36M	0.0%	+45.0%	0.008%
11/4/2022	Prudential Financial Inc.	31,782	$1.48M	0.0%	-88.9%	0.034%

Data available starting January 2016

Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company. It focuses on the discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system, or CNS. The firm's lead product candidate, ITI-007, is in clinical development as a first-in-class treatment for schizophrenia. It also includes pre-clinical programs that are focused on advancing drug candidates for the treatment of cognitive dysfunction, in both schizophrenia and Alzheimer's disease and for disease modification and the treatment of neurodegenerative disorders, including Alzheimer's disease. The company was founded by Paul Greengard and Sharon Mates in 2002 and is headquartered in New York, NY.

Today's Range

Now: $47.82

$47.44

$48.72

50 Day Range

MA: $50.81

$46.99

$54.45

52 Week Range

Now: $47.82

$42.42

$66.00

Volume

515,282 shs

Average Volume

582,996 shs

Market Capitalization

$4.53 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.1

Who are the company insiders with the largest holdings of Intra-Cellular Therapies?: Intra-Cellular Therapies' top insider shareholders include:
Sharon Mates (CEO)
Christopher D Alafi (Director)
Joel S Marcus (Director)
Mark Neumann (EVP)
Suresh K Durgam (Insider)
Lawrence J Hineline (CFO)
Nostrand Robert L Van (Director)
Lawrence J Hineline (CFO)
Michael Halstead (EVP)
Rory B Riggs (Director)
Learn More about top insider investors at Intra-Cellular Therapies.
Who are the major institutional investors of Intra-Cellular Therapies?: Intra-Cellular Therapies' top institutional shareholders include:
Bank of Montreal Can — 0.49%
Pinnacle Associates Ltd. — 0.21%
Pinnacle Associates Ltd. — 0.21%
New York State Common Retirement Fund — 0.14%
Assenagon Asset Management S.A. — 0.08%
State of New Jersey Common Pension Fund D — 0.06%
Learn More about top institutional investors of Intra-Cellular Therapies stock.
Which institutional investors are selling Intra-Cellular Therapies stock?: In the previous quarter, ITCI stock was sold by these institutional investors:
Allspring Global Investments Holdings LLC
Strs Ohio
DekaBank Deutsche Girozentrale
Vahanian & Associates Financial Planning Inc.
Pinnacle Associates Ltd.
Pinnacle Associates Ltd.
Quantum Private Wealth LLC
First Hawaiian Bank
During the last year, company insiders that have sold Intra-Cellular Therapies company stock include:
Sharon Mates (CEO)
Christopher D Alafi (Director)
Joel S Marcus (Director)
Mark Neumann (EVP)
Suresh K Durgam (Insider)
Lawrence J Hineline (CFO)
Nostrand Robert L Van (Director)
Lawrence J Hineline (CFO)
Learn More investors selling Intra-Cellular Therapies stock.
Which institutional investors are buying Intra-Cellular Therapies stock?: During the last quarter, ITCI stock was acquired by institutional investors including:
Assenagon Asset Management S.A.
Alpha DNA Investment Management LLC
Legato Capital Management LLC
Knights of Columbus Asset Advisors LLC
New York State Common Retirement Fund
Hennion & Walsh Asset Management Inc.
AE Wealth Management LLC
Natixis Advisors L.P.